Article

Oncologist compensation deserves evidence-based scrutiny and analysis


 

As community-based oncology practices have faced continued cutbacks in reimbursements under the Medicare Prescription Drug, Improvement, and Modernization Act and now through sequestration, many have had to close satellite sites, cut back on their supportive services, join networks – where possible – or hospitals or health systems, and scramble to engage payers in rethinking payment models. They have done so not only to cover their costs for the technological outlay, staffing, and other overheads necessary for them to provide quality oncology care, but also to ensure competitive compensation packages for their teams of highly trained, specialized physicians, midlevel practitioners, and nursing and administrative staff…

*Click on the link to the left for a PDF of the full article.

Recommended Reading

ASCO guidelines for fertility preservation affirm oocyte preservation
MDedge Hematology and Oncology
Oral HPV-related cancer risk not transmitted to sex partners
MDedge Hematology and Oncology
How will sequestration affect American cancer care?
MDedge Hematology and Oncology
Cancer health disparities and risk factors: lessons from a woman with a 20-cm chest wall mass, growing for 2 years
MDedge Hematology and Oncology
Opioid overdose deaths skyrocket in women
MDedge Hematology and Oncology
Practical considerations in the delivery of genetic counseling and testing services for inherited cancer predisposition
MDedge Hematology and Oncology
VTE rate triples in pediatric cancer survivors
MDedge Hematology and Oncology
Cancer survivors may have lower Alzheimer’s risk
MDedge Hematology and Oncology
Khorana score tracks risk of cancer death
MDedge Hematology and Oncology
Guidelines issued on radiation-induced heart disease
MDedge Hematology and Oncology